BDD vs. STeP | Proxima CRO
Автор: Proxima Clinical Research
Загружено: 2023-01-06
Просмотров: 62
Rob MacCuspie, Regulatory Manager at Proxima Clinical Research, is here to discuss the similarities and differences between two major FDA submission programs: Breakthrough Device Designation (BDD) and the Safer Technologies Program (STeP)!
The programs are closely related, so it's important to understand the nuances of both in order to best choose the path that's best for you and your product! Watch to learn more.
Proxima works with emerging biotech and medical device companies across all phases of development.
As a contract research organization, we organize our team in two distinct areas: early-stage advisory consulting and all-inclusive clinical trial services. The service you need. The speed you want. The attention you deserve.
Thanks for watching!
Website: https://proximacro.com/
Twitter: @ProximaCRO
LinkedIn: / proxima-clinical-research
Business email: [email protected]
Produced by:
Julian Lara, Videographer & Graphic Designer
Brandon Clements, Production Manager
Devin Finch, Creative Director
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: